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Objective: The objective of this selective EBM review is to determine whether or not “Is 
Comprehensive Behavioral Intervention for Tics (CBIT) effective in decreasing tic severity in 
individuals with chronic tic disorders?” 
 
Study Design: A systematic review of three randomized controlled trials (RCTs) published 
between 2010 and 2016. 
 
Data Sources: All three RCTs were discovered using PubMed. The articles were published in 
English in peer-reviewed journals and selected based on applicability to the clinical question. 
 
Outcome Measured: A reduction in tic severity was the outcome measured in all three studies 
using the Yale Global Tic Severity Score (YGTSS). Scores range from 0-100 with higher scores 
indicating stronger tic severity. The mean change from baseline was calculated once intervention 
was received. 
 
Results: In the RCT led by Wilhelm et al., CBIT led to a reduction in tic severity compared with 
the control group (P < 0.001), indicated by a mean change from baseline of 6.2. In the RCT by 
Piacentini et al., CBIT led to a reduction in tic severity compared with the control group (P < 
0.001), indicated by a mean change from baseline of 7.6. Lastly, Ricketts et al. demonstrated a 
reduction in tic severity with CBIT-VoIP (voice over internet protocol), indicated by a mean 
change from baseline of 7.25 with statistical significance of P < 0.01 in the CBIT treatment 
group. 
 
Conclusion: All three studies in this review demonstrated that CBIT led to significantly reduced 
tic severity as measured by the YGTSS. This suggests CBIT is an effective and beneficial 
method of treatment for chronic tic disorders. Further studies should explore online 
administration, treatment duration, and maintenance therapy. 
 

















Chronic tic disorders involve repeated, brief, rapid movements or vocalizations. The tics 
typically present as rapid movements such as blinking and/or vocalizations such as grunting. In 
order to classify as a chronic disorder, tics must be recurring. A more specific diagnosis of 
Tourette syndrome (TS) can be made when individuals have both motor and vocal tics for 
greater than one-year duration.1 Tics typically begin in childhood, with severity peaking in early 
adolescence, and declining in young adulthood. It is estimated that the prevalence of TS in 
children is 6 cases per 1,000; this analogizes to about 300,000 cases of TS among children in the 
United States.2 The estimated prevalence of TS in adults is 1 per 2,000.2 There is not an exact 
estimate available regarding annual health care utilization, however treatment of chronic tic 
disorders is multifaceted and includes neurology, psychology/psychiatry, speech therapy, and 
more subspecialty appointments, resulting in an immense amount of healthcare visits each year.3 
Similarly, the total healthcare cost of tic disorders has not been identified, but it is estimated that 
$117 million is spent annually on risperidone, a medication commonly used to treat tic 
disorders.3,4 
Tic disorders are complex neurological disorders thought to be caused by a combination 
of genetic and environmental factors, although the exact etiology is unknown. Many scientists 
believe them to be attributable to an abnormal release and uptake of dopamine. Chronic tic 
disorders are commonly associated with other psychiatric disorders including obsessive 
compulsive disorder and attention deficit hyperactivity disorder, leading to further psychosocial 
complications and difficulty maintaining a productive, independent, and/or self-sufficient 
lifestyle.2 Current treatment for chronic tic disorders is complex and multidimensional, usually 
involving both behavioral therapy and pharmacotherapy. Some pharmacologic options include 
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alpha-adrenergic agonists, such as clonidine and guanfacine, antipsychotics such as risperidone, 
haloperidol, and pimozide, antiepileptics such as topiramate, stimulants such as methylphenidate, 
SSRIs such as fluoxetine, and anxiolytics such as clonazepam. Other alternative methods include 
botulinum injections (Botox), psychotherapy, and deep brain stimulation (DBS). 
Medications play an effective role in treating chronic tic disorders but are not without 
consequences, often causing undesirable side effects. For example, antipsychotics can cause 
sedation and weight gain. The limitations of pharmacologic therapy highlight the importance of, 
and need for, alternative therapies. Comprehensive Behavioral Intervention for Tics (CBIT) is a 
nonpharmacologic treatment consisting of three key elements: training the patient to be more 
aware of their urge to tic, training patients to incorporate competing behavior when the urge to 
tic arises, as well as altering daily activities in ways which will help to reduce volume of tics.3 
This paper evaluates three randomized controlled trials (RCTs), assessing the efficacy of CBIT 
as a management for chronic tic disorders. 
OBJECTIVE 
 The objective of this selective EBM review is to determine whether or not “Is 
Comprehensive Behavioral Intervention for Tics (CBIT) effective in decreasing tic severity in 
individuals with chronic tic disorders?” 
METHODS 
 Studies were chosen based on credibility, applicability to the clinical question, and 
incorporation of patient-oriented outcomes. Further, they were selected if they fulfilled criteria 
based on population, intervention, comparison, and outcome measured. It was required that all 
studies were directed at patients clinically diagnosed with chronic tic disorders. The studies 
referenced in this review were found on PubMed using keywords “tic” and “comprehensive 
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behavior therapy”. It was required that the studies employed randomization and were published 
in peer-reviewed journals. All articles selected were in the English language. Inclusion criteria 
consisted of RCTs published after 2009. Studies published prior to 2009 were excluded. 
Statistical analyses utilized in these studies include the mean change from baseline in the Yale 
Global Tic Severity Score (YGTSS) as well as evaluating statistical significance using p-values. 
 The population of the studies targeted in this selective EBM review were patients 
diagnosed with a chronic tic disorder of moderate or greater severity. The demographics and 
characteristics of these studies can be found in Table 1. The intervention used in each study was 
CBIT. Authors Wilhelm et al. and Piacentini et al. compared CBIT with psychoeducation and 
supportive therapy (PST), whereas Ricketts et al. utilized a wait-list control group for 
comparison. The outcome measured that is discussed in this selective EBM is a reduction in tic 
severity. 
OUTCOME MEASURED 
 All three studies utilized the YGTSS, a rating determined by a physician based on a semi 
structured interview regarding tic number, frequency, intensity, complexity, and interference in 
the preceding week. The total tic score is calculated by totaling several component scores, 
including the overall impairment rating, total motor tic score (0-25), and total phonic tic score (0-
25).8 The overall impairment rating is on a 50-point scale, 0 indicating no impairment and 50 
indicating severe impairment.8 Scores range from 0-100 with higher scores indicating stronger 
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Table 1. Demographics & Characteristics of Included Studies 
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 All three studies in this review enrolled individuals diagnosed with a chronic tic disorder 
of moderate or greater severity and evaluated the safety and efficacy of CBIT. Wilhelm et al. 
conducted a randomized controlled trial using blinded raters. The authors enrolled patients 16 
years or older with a chronic tic disorder of moderate or greater severity. The study was 
conducted over 10 weeks and compared CBIT with psychoeducation and supportive therapy 
(PST). The primary outcome analyzed was the change in tic severity at the end of week 10. The 
cohort was comprised of 122 patients who were randomized in a 1:1 ratio to either CBIT or PST, 
and then stratified based on whether or not tic suppressing medication was prescribed, further 
improving accuracy.5 In total, 63 patients received CBIT while 53 patients received PST.5 
Although both patients and therapists were aware of treatment assignment, independent 
evaluators were masked to treatment conditions throughout the entirety of the trial. Both groups 
received eight sessions of either CBIT or PST for 10 weeks duration. Adverse events ranged 
from mild to severe, including myalgias, headaches, anxiety or depression, irritability, and sleep 
problems, however there was no evidence the adverse events were secondary to either 
intervention.5 In both groups, four subjects experienced tic worsening. Seven subjects 
discontinued treatment in the CBIT group, and 10 subjects discontinued in the PST group, but 
sufficient reason for discontinuation was not identified. Those individuals were not included in 
the final analysis.5 
 Assessments for efficacy and improvement in the YGTSS were observed after week 10 
of treatment. The authors used mean values to measure outcomes prior to and after treatment. 
The results were statistically significant (P < 0.001) in both interventions. The CBIT group 
showed a decrease in mean values with 24.0  6.5 prior to treatment and 17.8  7.3 at 10 weeks, 
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resulting in a mean change from baseline of 6.2.5 The PST group demonstrated a decrease in 
mean values with 21.8  6.6 prior to treatment and 19.3  7.4 at 10 weeks, resulting in a mean 
change from baseline of 2.5.5 The results are summarized in Table 2 below. CBIT was found to 
be superior to the control treatment, PST, as reflected by the 3.7-point difference between 
groups.5 These results compute to a 25.8% decrease from baseline to week 10 versus an 11.5% 
decrease for the control PST treatment.5 The presence of tic suppressing medication at baseline 
did not moderate treatment outcome as measured by the YGTSS. 
Table 2. YGTSS Change in Tic Severity from Baseline to Week 10 Follow-Up5  





from Baseline  
P-value 
CBIT group 24.0  6.5 17.8  7.3 6.2 <0.001 
PST group 21.8  6.6 19.3  7.4 2.5 <0.001 
  
Piacentini et al. conducted a trial with a very similar design as Wilhelm et al. but focused 
on children and adolescents from age 9-17 years old. Piacentini et al. conducted a randomized 
controlled trial using blinded raters. The authors enrolled patients 9-17 years old with a chronic 
tic disorder of moderate or greater severity. The study was conducted over 10 weeks and 
compared CBIT with psychoeducation and supportive therapy (PST). The primary outcome 
analyzed was the change in tic severity at the end of week 10. The cohort was comprised of 126 
patients who were randomized in a 1:1 ratio to either CBIT or PST, and then stratified based on 
whether or not tic suppressing medication was prescribed, further improving accuracy. In total, 
61 patients received CBIT while 65 patients received PST.6 Although both patients and therapists 
were aware of treatment assignment, independent evaluators were masked to treatment 
conditions throughout the entirety of the trial. Both groups received eight sessions of either CBIT 
or PST for 10 weeks duration. Adverse events ranged from mild to severe, including irritability 
and explosive behavior, myalgias, headaches, disruptive behavior, and fatigue, however there 
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was no evidence the adverse events were secondary to either intervention.6 One individual in the 
CBIT treatment group experienced tic worsening versus four in the PST treatment group. Five 
subjects discontinued treatment in the CBIT group and seven discontinued in the PST group. All 
126 subjects were included in primary data analysis, but a worst-case analysis was not 
preformed.6  
 Assessments for efficacy and improvement in the YGTSS were observed after week 10 
of treatment. Mean values with a 95% CI were used to measure outcomes both prior to and after 
treatment. The results were statistically significant (P < 0.001) in both interventions. The CBIT 
group showed a decrease in mean values with 24.7 (23.1 – 26.3) prior to treatment and 17.1 (15.1 
– 19.1) at 10 weeks, resulting in a mean change from baseline of 7.6.6 The PST group 
demonstrated a decrease in mean values with 24.6 (23.2 – 26.0) prior to treatment and 21.1 (19.2 
– 23.0) at 10 weeks, resulting in a mean change from baseline of 3.5.6 The results are 
summarized in Table 3 below. This 4.1-point difference between groups is clinically meaningful, 
indicating CBIT was superior to the control treatment, PST, with a 51% decrease from baseline 
to week 10 compared with a 30% decrease for the control treatment.6 The presence of tic 
suppressing medication at baseline did not moderate treatment outcome as measured by the 
YGTSS. 
Table 3. YGTSS Change in Tic Severity from Baseline to Week 10 Follow-Up6  
 Before Treatment 
Mean (95% CI) 
Week 10 




CBIT group 24.7 (23.1- 26.3)  17.1 (15.1-19.1) 7.6 <0.001 
PST group 24.6 (23.2-26.0) 21.1 (19.2-23.0) 3.5 <0.001 
 
Ricketts et al. also conducted a randomized controlled trial of subjects diagnosed with a 
chronic tic disorder. Subjects ranged from 8-16 years old. Tic scores were measured by blinded 
raters. The study was a 10-week RCT comparing CBIT-VoIP (voice over internet protocol) to a 
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waitlist control group. Participations in the CBIT-VoIP received CBIT by method of video 
conference. The primary outcome analyzed was the change in tic severity at the end of week 10. 
Treatment consisted of two 1.5-hour sessions followed by six one-hour sessions occurring over a 
10-week period. The cohort was comprised of 20 patients who were randomized to either CBIT-
VoIP or waitlist control group, and then stratified with respect to medication status and gender.7 
A total of 12 patients were assigned to receive CBIT-VoIP while eight patients were allocated to 
the waitlist.7 Patients were informed of group assignment via phone after baseline and 
independent evaluators were masked to treatment conditions throughout the entirety of the trial. 
Adverse events were not indicated. One subject discontinued treatment in the CBIT-VoIP group, 
however, no one discontinued waitlist position. All 20 subjects were included in data analysis.7 
Assessments for efficacy and improvement in the YGTSS were observed after week 10 
of treatment. Mean values were used to measure outcomes both prior to and after treatment. The 
results were statistically significant (P < 0.01) in the CBIT-VoIP group, whereas the waitlist 
control group was not precise (P = 0.15).7 The CBIT-VoIP group showed a decrease in mean 
values with 25.75 prior to treatment and 18.50 at 10 weeks, resulting in a mean change from 
baseline of 7.25.7 The waitlist control group demonstrated a decrease in mean values with 22.0 
prior to treatment and 20.25 at 10 weeks, resulting in a mean change from baseline of 1.75.7 The 
results are summarized in Table 4 below.  









CBIT-VoIP group 25.75 18.50 7.25 <0.01 
Waitlist group 22.00 20.25 1.75 0.15 
 
 




 Chronic tic disorders are a life-altering condition for which there is currently no cure, 
supporting the need for new treatment methods. Compared to pharmacologic treatments, 
nonpharmacologic treatments are beneficial in that they lack systemic side effects; however, they 
are more time-consuming to complete and thus patient and family compliance is more 
challenging. Additionally, because it is a newer development, there are a limited number of 
healthcare professionals trained on providing proper and effective CBIT to patients. Another 
barrier to CBIT may be cost. Limited insurance coverage, high co-pays, and travel costs 
associated with frequent sessions can be significant, rendering it an unaffordable option for some 
patients and families. 
 This review evaluated the efficacy of Comprehensive Behavioral Intervention for Tics as 
a treatment resulting in a reduction in tic severity in those with chronic tic disorders. All three 
studies found statistically significant improvement in the Yale Global Tic Severity Score after 
intervention with CBIT, with a substantial mean change from baseline in CBIT groups, a 
statistically significant p-value and large effect sizes. This proves not only that CBIT is more 
effective than the control groups of PST and waitlist, but to a significant magnitude. Ricketts et 
al. was especially promising, as CBIT was still determined to be effective when administered via 
VoIP, eliminating the time and cost commitment of travel. The results from this study support 
the efficacy of this therapy and indicate an improvement in quality of life. 
All three studies had limitations. Patients were unable to be kept “blind” to treatment, 
leaving the potential for a false sense of improvement and bias due to subjects being aware of 
their treatment intervention. This bias most likely would be in favor of CBIT and could 
compromise results, falsely indicating a greater reduction in tics by CBIT than actually produced 
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in practice. The use of blinded raters alleviates some of this concern but does not eliminate the 
risk of bias altogether. Additionally, Ricketts et al. used a small sample size, affecting the 
validity and reliability of these results. Lastly, Wilhelm et al. and Piacentini et al. did not perform 
worst case analyses for missing outcome data from subjects lost during their respective trials. 
This factor also introduces bias within these studies and make them less valid.  
CONCLUSION 
 This systematic review showed Comprehensive Behavioral Intervention for Tics to be 
effective in decreasing tic severity in individuals with chronic tic disorders. Wilhelm et al., 
Piacentini et al., and Ricketts et al. all found CBIT to cause a statistically significant mean 
decrease in YGTSS after 10 weeks of treatment. The chance for any improvement in tics in those 
with chronic tic disorders is deserving of further exploration as quality of life can be much 
improved with a decrease in frequency and severity of tics. In order to further demonstrate the 
potential CBIT has, additional trials should be performed with an even larger sample size and 
duration. It would be beneficial to conduct further studies to determine the minimum number of 
treatment sessions required to reduce tic severity, as well as investigate long-term maintenance 
sessions to keep tic severity low. Additionally, it would be of great benefit to further explore the 
administration of CBIT online as it makes treatment more compatible with a busy lifestyle.  
 Another possibility to be explored is initiating CBIT immediately upon diagnosis. CBIT 
may be more beneficial if started earlier because recognizing the urge of a tic early, as well as 
learning how to prevent it quickly, may train the brain to resist tics at a more formative stage of 
the disease and potentially slow progression. This way, tic disorders may never have the chance 
to become severe. Early intervention would require individualized therapy such that it accounts 
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for differences in a child’s various phases of development. Implementing personalized delivery 
strategies can lead to better absorption, and thus an increased effectiveness of CBIT. 
 There is currently a trial of Internet based CBIT being sponsored by Tel Aviv Medical 
Center in a sample of children and adolescents 8-17 years old with chronic tic disorders.9 It was 
estimated to be completed in 2020 however is still ongoing. If found to be effective, this has the 
potential to significantly reduce overall cost and treatment burden placed on those with living 
with a chronic tic disorder. Hopefully, future studies will be able to identify the most successful 
implication and utilization of CBIT, so those with chronic tic disorders can have an improved 
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